Amylyx Pharmaceuticals, Inc. (AMLX)
NMS – Real vaqt narxi. Valyuta: USD
14.44
-0.44 (-2.96%)
Yopilishda: May 12, 2026, 4:00 PM EDT
14.55
+0.11 (0.76%)
Bozor oldidan: May 13, 2026, 4:44 AM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
14.44
-0.44 (-2.96%)
Yopilishda: May 12, 2026, 4:00 PM EDT
14.55
+0.11 (0.76%)
Bozor oldidan: May 13, 2026, 4:44 AM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 17.85 | 2.52 | 10 | |
| Tezkor likvidlik nisbati | 17.85 | 1.78 | 10 | |
| Qarz/Kapital nisbati | 0.02 | -0.80 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.02 | 0.73 | 9.0 | |
| Foiz to‘lov qoplami | N/A | -13.90 | 1.0 | |
| O‘rtacha ball | 7.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 22M | 381M | 87M | N/A | N/A |
| Yalpi foyda | 19M | 354M | -38M | -525K | -467K |
| Operatsion daromad | -201M | 39M | -256M | -153M | -159M |
| Sof foyda | -198M | 49M | -302M | -145M | -150M |
| EBITDA | -201M | 40M | -255M | -153M | -159M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 24.25 | 5.5 |
| Keyingi chorak | N/A | 8.56 | 3.5 |
| Joriy yil | N/A | 6.8 | 3.0 |
| Keyingi yil | N/A | 9.95 | 3.5 |
| O‘rtacha ball | 3.9 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | -25.1 | -23.32 | -31.76 | 3.3 |
| Yil/Yil | 999 | -14.96 | 11.9 | 7.41 | 5.8 |
| 3 yil o‘rtacha | 478.63 | -178.5 | -182.24 | -513.06 | 3.3 |
| 5 yil o‘rtacha | 1815.95 | -153.81 | -118.02 | -357.16 | 3.3 |
| O‘rtacha ball | 3.9 | ||||
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Kompaniyaning naqd pul zahiralari $229.1M umumiy qarzdan $5.6M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $285.0M jami joriy majburiyatlardan $16.0M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasidan (-0.8) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$36.9M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi